Risperidone versus other atypical antipsychotic medication for schizophrenia
Editorial Group: Cochrane Schizophrenia Group
Published Online: 24 JUL 2000
Assessed as up-to-date: 23 MAY 2000
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Gilbody S, Bagnall AM, Duggan L, Tuunainen A. Risperidone versus other atypical antipsychotic medication for schizophrenia. Cochrane Database of Systematic Reviews 2000, Issue 3. Art. No.: CD002306. DOI: 10.1002/14651858.CD002306.
- Publication Status: Edited (no change to conclusions)
- Published Online: 24 JUL 2000
This article has been cited by:
- 1Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS), Schizophrenia Research, 2012, 134, 2-3, 187, , , , , , , , , , , , , ,
- 2Non-hormonal Systemic Medications and Dry Eye, The Ocular Surface, 2011, 9, 4, 212, , , ,
- 3Atypical Antipsychotic Drugs for Schizophrenia, Mayo Clinic Proceedings, 2003, 78, 3, 381,
- 4The new and evolving pharmacotherapy of schizophrenia, Psychiatric Clinics of North America, 2003, 26, 1, 141, ,